Atlas Trials

A Comparison Study of the Bioavailability of a Capsule Formulation of LGD-6972 to an Oral Solution Formulation

Clinical trial NCT02672839 · COMPLETED

Trial details

NCT number
NCT02672839
Sponsor
Ligand Pharmaceuticals
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Type 2 Diabetes Mellitus (T2DM)
Start date
2016-02-01
Primary completion
2016-05-01
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.